Australia's largest stock trading and investment forum Australia's #1 stock forum

The blind control group studies say it doesn't work,...

First 5 Last

Share
Profile

Follow
fdKen

8,743 Posts.

71

05/08/20

07:34

Post #: 46306271
Share

Originally posted by chris: ↑

Meh, he works for big pharma. And so what if it doesn't work, why ban it? At least let people try it.

It's all a ruse.
.

Therefore, the odds of hospitalization of treated patients were 84% less than in the untreated group. One patient (0.7%) died in the treatment group versus 13 patients (3.5%) in the untreated group (odds ratio 0.2, 95% CI 0.03-1.5; p=0.16). There were no cardiac side effects. Conclusions: Risk stratification-based treatment of COVID-19 outpatients as early as possible after symptom onset with the used triple therapy, including the combination of zinc with low dose hydroxychloroquine, was associated with significantly less hospitalizations and 5 times less all-cause deaths.

Expand

The blind control group studies say it doesn't work, against that any retrospective study is meaningless
2 Upvote

Reply

Top Stories

Trump chides Powell as Goldman call for calm. The RBA must be nervous

Week 27 Wrap: 40% China tariffs?; ASX +10% FY25; US Amazon price spike

NMG

New Murchison Gold blasts off at Crown Prince as 'better than expected' results return

OSL

OncoSil wraps up recruitment for key pancreatic cancer trial

THL

Tourism Holdings says Liberation Day tariffs smashed US RV demand

AII

Inside the Depths of Panasqueira: A Legacy Carved in Rock

HotCopper Highlights, Week 27: G8 scalped, Domino’s drops the box, Gemlife brief hype & more

Listen: HotCopper Wire Podcast 016 – FY25 ended up not so bad... but Trump unpause is coming

KGD

Kula picks up unexplored niobium play in Malawi, with surface samples logged

DMP

Is Domino's a steal after -25% plunge?

First 5 Last

SPONSORED BY